|
US4443442A
(en)
|
1979-12-21 |
1984-04-17 |
Skillern Scott D |
Method and composition for treatment of acne vulgaris
|
|
AU8952282A
(en)
|
1982-08-25 |
1984-03-29 |
Joel E. Bernstein |
Method of treating pruritis and composition therefor
|
|
US4720384A
(en)
|
1985-05-03 |
1988-01-19 |
E. I. Du Pont De Nemours And Company |
Manufacture of hollow fine tubular drug delivery systems
|
|
US20010006967A1
(en)
|
1992-09-21 |
2001-07-05 |
Stanley M. Crain |
Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists
|
|
US6239154B1
(en)
|
1996-03-08 |
2001-05-29 |
Adolor Corporation |
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
DE69732868T2
(de)
|
1996-11-25 |
2006-04-13 |
Toray Industries, Inc. |
Mittel gegen Juckreiz
|
|
US6787149B1
(en)
|
1996-12-12 |
2004-09-07 |
El Khoury And Stein Ltd. |
Topical application of opioid analgesic drugs such as morphine
|
|
US6896899B2
(en)
*
|
1996-12-31 |
2005-05-24 |
Antioxidant Pharmaceuticals Corp. |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
US5760023A
(en)
|
1997-07-14 |
1998-06-02 |
Adolor Corporation |
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
|
|
CA2288828A1
(en)
|
1997-07-14 |
1999-01-28 |
Adolor Corporation |
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
|
US6274591B1
(en)
|
1997-11-03 |
2001-08-14 |
Joseph F. Foss |
Use of methylnaltrexone and related compounds
|
|
CN100340575C
(zh)
|
1999-06-25 |
2007-10-03 |
杰南技术公司 |
人源化抗ErbB2抗体及其在制备药物中的应用
|
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
|
US6451806B2
(en)
|
1999-09-29 |
2002-09-17 |
Adolor Corporation |
Methods and compositions involving opioids and antagonists thereof
|
|
JP2001163784A
(ja)
|
1999-12-06 |
2001-06-19 |
Toray Ind Inc |
角膜または結膜用止痒剤
|
|
DE19960154A1
(de)
*
|
1999-12-14 |
2001-07-12 |
Lohmann Therapie Syst Lts |
Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
|
|
JP4370683B2
(ja)
|
2000-05-08 |
2009-11-25 |
東レ株式会社 |
そう痒疾患の検査方法
|
|
DE10116978A1
(de)
|
2001-04-05 |
2002-10-10 |
Merck Patent Gmbh |
Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
|
|
ITMI20010907A1
(it)
|
2001-05-02 |
2002-11-02 |
Valpharma Sa |
Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidi
|
|
US20030054030A1
(en)
|
2001-09-13 |
2003-03-20 |
Gary Gordon |
Method and compositions for the treatment of pruritus
|
|
ES2654819T3
(es)
|
2001-10-18 |
2018-02-15 |
Nektar Therapeutics |
Conjugados poliméricos de antagonistas de opioides
|
|
US6703398B2
(en)
|
2001-11-26 |
2004-03-09 |
Oliver Yoa-Pu Hu |
Orally administered analgesic compositions containing nalbuphine
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
EP1492505B1
(en)
|
2002-04-05 |
2015-06-03 |
Euro-Celtique S.A. |
Pharmaceutical preparation containing oxycodone and naloxone
|
|
US20030191147A1
(en)
|
2002-04-09 |
2003-10-09 |
Barry Sherman |
Opioid antagonist compositions and dosage forms
|
|
DE10229842A1
(de)
|
2002-07-03 |
2004-02-05 |
Helmut Prof. Dr. Schmidhammer |
Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
|
|
WO2004008099A2
(en)
|
2002-07-15 |
2004-01-22 |
Genentech, Inc. |
METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
|
|
SI2263691T1
(sl)
|
2002-07-15 |
2012-12-31 |
F. Hoffmann-La Roche Ag |
Zdravljenje raka z rekombinantnim humaniziranim monoklonskim anti-ErbB2 protitelesom 2C4 (rhuMAb 2C4)
|
|
US7381721B2
(en)
|
2003-03-17 |
2008-06-03 |
Adolor Corporation |
Substituted piperidine compounds
|
|
CA2811272C
(en)
|
2003-04-08 |
2016-12-20 |
Progenics Pharmaceuticals, Inc. |
Pharmaceutical formulations containing methylnaltrexone
|
|
US7459146B2
(en)
|
2003-05-30 |
2008-12-02 |
3M Innovative Properties Company |
Stabilized aerosol dispersions
|
|
MXPA06003392A
(es)
|
2003-09-25 |
2006-06-08 |
Euro Celtique Sa |
Combinacion farmaceutica de hidrocodona y naltrexona.
|
|
TW200533355A
(en)
|
2004-03-30 |
2005-10-16 |
Toray Industries |
Antipruritic agent
|
|
AU2005249581A1
(en)
|
2004-06-03 |
2005-12-15 |
Jonathan J. Burbaum |
Pharmaceutical compositions for the treatment of pruritus
|
|
US20060063792A1
(en)
|
2004-09-17 |
2006-03-23 |
Adolor Corporation |
Substituted morphinans and methods of their use
|
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
|
PL1888033T3
(pl)
|
2005-06-09 |
2014-09-30 |
Meda Ab |
Sposób i kompozycja do leczenia chorób zapalnych
|
|
US8394812B2
(en)
*
|
2005-08-24 |
2013-03-12 |
Penwest Pharmaceuticals Co. |
Sustained release formulations of nalbuphine
|
|
EP1931315B1
(en)
|
2005-08-24 |
2013-10-16 |
Penwest Pharmaceuticals Co. |
Sustained release formulations of nalbuphine
|
|
EP1942903A4
(en)
|
2005-08-30 |
2011-01-12 |
Univ Kingston |
POTENTIATING THE THERAPEUTIC EFFECT OF AN OPIOID RECEPTOR AGONIST AND / OR INHIBITING OR REVERSING THE TOLERANCE FOR OPIOID RECEPTOR AGONISTS WITH A ULTRANOUS DOSE OF AN ALPHA-2 RECEPTOR ANTAGONIST
|
|
EP2749571A3
(en)
|
2006-01-10 |
2014-08-13 |
ZymoGenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using IL-31RA and OSMRb antagonists
|
|
WO2008024490A2
(en)
|
2006-08-24 |
2008-02-28 |
Theraquest Biosciences, Inc. |
Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use
|
|
JP2008109898A
(ja)
|
2006-10-31 |
2008-05-15 |
Toray Ind Inc |
鎮痒作用を有する化合物のスクリーニング方法
|
|
RU2500685C2
(ru)
|
2006-11-10 |
2013-12-10 |
Кара Терапеутикс, Инк |
Синтетические пептидные амиды
|
|
EP2101774A2
(en)
|
2006-11-22 |
2009-09-23 |
Progenics Pharmaceuticals, Inc. |
7,8-saturated-4,5-epoxy-morphinanium analogs
|
|
BRPI0719327A2
(pt)
|
2006-11-22 |
2014-02-04 |
Progenics Pharm Inc |
N-óxidos de análogos de 4,5-epóxi-morfinano
|
|
JP2010510325A
(ja)
|
2006-11-22 |
2010-04-02 |
プロジェニックス ファーマスーティカルス インコーポレーテッド |
７，８−飽和−４，５−エポキシ−モルフィナニウム類似体の（ｓ）−ｎ−立体異性体
|
|
US20080207667A1
(en)
|
2007-02-23 |
2008-08-28 |
Rhame Robert W |
Use of nalbuphine and related compounds to treat symptoms of respiratory problems
|
|
PL2137191T3
(pl)
|
2007-03-29 |
2016-12-30 |
|
Antagoniści obwodowego receptora opioidowego i ich zastosowania
|
|
CA2682608A1
(en)
|
2007-03-30 |
2008-10-09 |
Tioga Pharmaceuticals, Inc. |
Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
|
|
CL2008001112A1
(es)
|
2007-04-20 |
2008-12-19 |
Novartis Ag |
Usos de compuestos derivados de pirido[2,3-d]pirimidin-4-ona para tratar comezon o un trastorno relacionado con comezon; combinacion de los compuestos con otro farmaco; y uso de la combinacion para tratar la comezon o un trastorno relacionado con comezon.
|
|
ES2396600T3
(es)
|
2007-04-23 |
2013-02-22 |
Symrise Ag |
Ésteres de polietilenglicol y preparaciones cosméticas y/o dermatológicas
|
|
BRPI0813230A2
(pt)
|
2007-06-28 |
2014-12-23 |
Novartis Ag |
Moduladores de calicreína 7
|
|
AU2008296905A1
(en)
|
2007-09-04 |
2009-03-12 |
Alpharma Pharmaceuticals, Llc |
A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
|
|
WO2009047562A1
(en)
|
2007-10-08 |
2009-04-16 |
Serentis Limited |
Methods and compositions for the treatment of pruritus
|
|
WO2009070733A1
(en)
|
2007-11-26 |
2009-06-04 |
Pharmacofore, Inc. |
Peripheral phenolic opioid antagonist
|
|
ES2671897T3
(es)
|
2008-02-14 |
2018-06-11 |
Alkermes, Inc. |
Compuestos opioides selectivos
|
|
US8686040B2
(en)
|
2008-03-31 |
2014-04-01 |
Rdd Pharma Ltd. |
Method for treating anal pruritis and other perianal disorders
|
|
WO2009132313A2
(en)
|
2008-04-25 |
2009-10-29 |
Progenics Pharmaceuticals, Inc. |
Morphinan derivatives of organic and inorganic acids
|
|
CA2740440A1
(en)
*
|
2008-10-14 |
2010-04-22 |
Dyax Corp. |
Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis-associated pulmonary fibrosis
|
|
US20120077803A1
(en)
|
2009-02-24 |
2012-03-29 |
Novartis Ag |
Uses Of NK Receptor Antagonists
|
|
US20100227876A1
(en)
|
2009-03-06 |
2010-09-09 |
Rechfensen Llp |
Methods of Reducing Side Effects of Analgesics
|
|
EP2408303A4
(en)
|
2009-03-19 |
2012-07-25 |
Alkermes Inc |
MORPHINANE DERIVATIVES HAVING HIGH ORAL BIOLOGICAL AVAILABILITY
|
|
EP2421515A2
(de)
|
2009-04-22 |
2012-02-29 |
Lars Holger Hermann |
Partikelförmige pharmazeutische zusammensetzung mit einem opioid und einem opioid- antagonisten
|
|
GB201111485D0
(en)
*
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
CA2709800C
(en)
*
|
2009-07-15 |
2023-01-10 |
Universite Laval |
Method and device for administering oxygen to a patient and monitoring the patient
|
|
PH12012501552A1
(en)
|
2010-01-29 |
2017-04-26 |
Toray Industries |
Therapeutic or prophylactic agent for biliary diseases
|
|
IT1398930B1
(it)
|
2010-03-24 |
2013-03-28 |
Molteni & C |
Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi.
|
|
FR2963889B1
(fr)
*
|
2010-08-20 |
2013-04-12 |
Debregeas Et Associes Pharma |
Formulations a base de nalbuphine et leurs utilisations
|
|
JP2012087101A
(ja)
|
2010-10-21 |
2012-05-10 |
Holger Hermann Lars |
オピオイドおよびオピオイド拮抗薬を含む微粒子医薬組成物
|
|
KR20220044385A
(ko)
|
2012-12-14 |
2022-04-07 |
트레비 테라퓨틱스, 인코포레이티드 |
소양증을 치료하는 방법
|
|
US20140179727A1
(en)
|
2012-12-14 |
2014-06-26 |
Trevi Therapeutics, Inc. |
Methods for treating pruritus
|
|
US8987289B2
(en)
|
2012-12-14 |
2015-03-24 |
Trevi Therapeutics, Inc. |
Methods for treating pruritus
|
|
US8637538B1
(en)
|
2012-12-14 |
2014-01-28 |
Trevi Therapeutics, Inc. |
Methods for treatment of pruritis
|
|
AU2014308606B2
(en)
*
|
2013-08-23 |
2017-08-03 |
Afferent Pharmaceuticals Inc. |
Diaminopyrimidine P2X3 and P2X 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough
|
|
WO2015192071A1
(en)
|
2014-06-13 |
2015-12-17 |
Trevi Therapeutics, Inc. |
Methods for treating pruritus
|
|
TW201735914A
(zh)
*
|
2015-12-22 |
2017-10-16 |
阿斯特捷利康公司 |
用於治療慢性阻塞性肺疾病之醫藥組成物
|
|
EP3393463B1
(en)
*
|
2015-12-23 |
2021-01-20 |
Conrig Pharma ApS |
Suplatast tosilate for treating cough associated with interstitial lung disease
|
|
US20170216277A1
(en)
|
2016-01-06 |
2017-08-03 |
Trevi Therapeutics, Inc. |
Therapeutic use of nalbuphine without aquaretic effects
|
|
DK3377064T3
(da)
*
|
2016-01-08 |
2019-09-23 |
Nerre Therapeutics Ltd |
Orvepitant til behandling af kronisk hoste
|
|
CN105560202B
(zh)
|
2016-03-11 |
2019-05-24 |
广州玻思韬控释药业有限公司 |
一种盐酸纳布啡凝胶骨架缓释片的制备方法及应用
|
|
CN109310656A
(zh)
|
2016-03-21 |
2019-02-05 |
特雷维治疗股份有限公司 |
尿毒症性瘙痒症的治疗
|
|
US20190247373A1
(en)
*
|
2016-07-14 |
2019-08-15 |
Children's Hospital Medical Center |
Methods for treating fibrosis
|
|
WO2018044942A1
(en)
*
|
2016-08-31 |
2018-03-08 |
Patara Pharma, LLC |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
|
MX2019004804A
(es)
|
2016-10-25 |
2019-08-22 |
Trevi Therapeutics Inc |
Tratamiento para el prurigo nodula.
|
|
CN112672743A
(zh)
|
2018-07-11 |
2021-04-16 |
特雷维治疗股份有限公司 |
肝病瘙痒症状的治疗
|
|
IL318587A
(en)
|
2018-07-23 |
2025-03-01 |
Trevi Therapeutics Inc |
Treatment of chronic cough, shortness of breath and wheezing
|